Foresite Capital Fund IV, L.P.
10% Owner

Foresite Capital Fund IV, L.P. insider trades: Eikon Therapeutics (EIKN) stock buys and sales

10% Owner, Eikon Therapeutics Last trade Feb 4, 2026 17 Form 4 filings
$0
Sold, last 12 months
0 sales
$1000K
Bought, last 12 months
1 buy
8
Open-market trades
since 2019
4
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Foresite Capital Fund IV, L.P. reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
Feb 4, 2026EIKN↑ Buy$1000K
May 8, 2023KNTE↑ Buy$5.0M
Feb 27, 2020AERI↓ Sell$17.1M
Sep 5, 2019AERI↑ Buy$2.1M
Sep 3, 2019AERI↑ Buy$1.6M
Aug 23, 2019AERI↑ Buy$1.1M
Aug 20, 2019AERI↑ Buy$3.7M
Aug 14, 2019AERI↑ Buy$13.3M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other EIKN insiders

Open-market trades in the last 12 months

About Foresite Capital Fund IV, L.P.'s insider trades

Foresite Capital Fund IV, L.P. is a 10% owner of Eikon Therapeutics (EIKN). Since Aug 14, 2019, it has reported 7 open-market purchases worth $27.8M and 1 sale worth $17.1M on SEC Form 4. In the last 12 months: 1 buy ($1000K).

Its filings also include option exercises (4 filings), conversions (2 filings), other transactions (2 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every EIKN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.